An investigator-sponsored paediatric trial of MOR-208 in combination with an immune cell transplantation for Acute-lymphoblastic-leukaemia

Trial Profile

An investigator-sponsored paediatric trial of MOR-208 in combination with an immune cell transplantation for Acute-lymphoblastic-leukaemia

Planning
Phase of Trial: Phase I/II

Latest Information Update: 08 Sep 2015

At a glance

  • Drugs MOR 208 (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Sep 2015 According to Morpho Sys media release, company is planning to start enrolment in the first half of 2016.
    • 12 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top